Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    11730997 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: AFATINIB;   Drug: Placebo of  AFATINIB
2 Active, not recruiting Phase II Trial Evaluating Elimination of Radiation Therapy
Condition: Cancer of the Larynx
Intervention: Radiation: IMRT

Indicates status has not been verified in more than two years